Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Liver Neoplasms"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 77224
Tytuł:
6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation.
Autorzy:
Chaudhary CL; College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
Lim D; Innovo Therapeutics Inc, Daejeon, Republic of Korea.
Chaudhary P; College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
Guragain D; College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
Awasthi BP; College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
Park HD; Innovo Therapeutics Inc, Daejeon, Republic of Korea.
Kim JA; College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
Jeong BS; College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
Pokaż więcej
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2022 Dec; Vol. 37 (1), pp. 844-856.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Design*
Antineoplastic Agents/*pharmacology
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Pyridines/*pharmacology
Pyrimidines/*pharmacology
Animals ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Carcinoma, Hepatocellular/pathology ; Cell Proliferation/drug effects ; Chickens ; Dose-Response Relationship, Drug ; Humans ; Liver Neoplasms/pathology ; Liver Neoplasms, Experimental/drug therapy ; Liver Neoplasms, Experimental/pathology ; Models, Molecular ; Molecular Structure ; Pyridines/chemical synthesis ; Pyridines/chemistry ; Pyrimidines/chemical synthesis ; Pyrimidines/chemistry ; Structure-Activity Relationship ; Tumor Cells, Cultured
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
FDG metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal cancer liver metastasis.
Autorzy:
Lee HS; Department of Nuclear Medicine, GangNeung Asan Hospital, University of Ulsan College of Medicine, 38 Bangdong-gil, Sacheon-myeon, Gangneung-si, Gangwon-do, 25440, Republic of Korea. .
Kwon HW; Department of Nuclear Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Lim SB; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim JC; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Yu CS; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Hong YS; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Oh M; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Han S; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Oh JH; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
Park S; Department of Nuclear Medicine, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
Kim TS; Department of Nuclear Medicine, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
Kim SK; Department of Nuclear Medicine, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
Kim HJ; Department of Nuclear Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Kwak JY; Department of Surgery, GangNeung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.
Oh HS; Division of Hemato-oncology in the Department of Internal Medicine, GangNeung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.
Kim S; Department of Nuclear Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Kwak JM; Department of Surgery, Korea University College of Medicine, Seoul, Republic of Korea.
Lee JS; Clinical Research Center in the Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim JS; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Mar; Vol. 33 (3), pp. 1746-1756. Date of Electronic Publication: 2022 Sep 17.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Neoplasms*/secondary
Colorectal Neoplasms*/surgery
Colorectal Neoplasms*/pathology
Male ; Humans ; Fluorodeoxyglucose F18 ; Positron Emission Tomography Computed Tomography ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Is it possible to use low-dose deep learning reconstruction for the detection of liver metastases on CT routinely?
Autorzy:
Lyu P; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, No.1 East Jianshe Road, Zhengzhou, 450052, Henan Province, China.; Department of Radiology, Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC, 27710, USA.
Liu N; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, No.1 East Jianshe Road, Zhengzhou, 450052, Henan Province, China.
Harrawood B; Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, Duke University Medical Center, 2424 Erwin Road, Suite 302, Durham, NC, 27705, USA.
Solomon J; Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, Duke University Medical Center, 2424 Erwin Road, Suite 302, Durham, NC, 27705, USA.
Wang H; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, No.1 East Jianshe Road, Zhengzhou, 450052, Henan Province, China.
Chen Y; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, No.1 East Jianshe Road, Zhengzhou, 450052, Henan Province, China.
Rigiroli F; Beth Israel Deaconess Medical Center Department of Radiology, Harvard Medical School, 1 Deaconess Rd, 330 Brookline Ave, Boston, MA, 02215, USA.
Ding Y; Department of Radiology, Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC, 27710, USA.; Department of Radiology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 20032, China.
Schwartz FR; Department of Radiology, Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC, 27710, USA.
Jiang H; Department of Radiology, Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC, 27710, USA.; Department of Radiology, West China Hospital of Sichuan University, 37 Guoxue Alley, Chengdu, 610041, Sichuan Province, China.
Lowry C; Clinical Imaging Physics Group, Duke University Health System, 2424 Erwin Rd, Ste. 302, Durham, NC, 27705, USA.
Wang L; CT Imaging Research Center, GE Healthcare China, No.1 Tongji South Road, Beijing, 100176, China.
Samei E; Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, Duke University Medical Center, 2424 Erwin Road, Suite 302, Durham, NC, 27705, USA.
Gao J; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, No.1 East Jianshe Road, Zhengzhou, 450052, Henan Province, China. .
Marin D; Department of Radiology, Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC, 27710, USA.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Mar; Vol. 33 (3), pp. 1629-1640. Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:
Equivalence Trial; Journal Article
MeSH Terms:
Deep Learning*
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/secondary
Humans ; Algorithms ; Image Processing, Computer-Assisted ; Phantoms, Imaging ; Prospective Studies ; Radiation Dosage ; Radiographic Image Interpretation, Computer-Assisted/methods ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Preoperative transarterial chemoembolization with drug-eluting beads (DEB-TACE) in patients undergoing conversional hepatectomy: a propensity-score matching analysis.
Autorzy:
Liu Y; Colorectal Cancer Centre, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineering Research Centre of Colorectal Cancer Minimally Invasive, Shanghai, China.
Zhou B; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Tang W; Colorectal Cancer Centre, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineering Research Centre of Colorectal Cancer Minimally Invasive, Shanghai, China.
Xu D; Colorectal Cancer Centre, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yan Z; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Ren L; Colorectal Cancer Centre, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineering Research Centre of Colorectal Cancer Minimally Invasive, Shanghai, China.
Zhu D; Colorectal Cancer Centre, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineering Research Centre of Colorectal Cancer Minimally Invasive, Shanghai, China.
He G; Colorectal Cancer Centre, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineering Research Centre of Colorectal Cancer Minimally Invasive, Shanghai, China.
Wei Y; Colorectal Cancer Centre, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineering Research Centre of Colorectal Cancer Minimally Invasive, Shanghai, China.
Chang W; Colorectal Cancer Centre, Zhongshan Hospital, Fudan University, Shanghai, China. chang_.; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. chang_.; Shanghai Engineering Research Centre of Colorectal Cancer Minimally Invasive, Shanghai, China. chang_.
Xu J; Colorectal Cancer Centre, Zhongshan Hospital, Fudan University, Shanghai, China. .; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. .; Shanghai Engineering Research Centre of Colorectal Cancer Minimally Invasive, Shanghai, China. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Feb; Vol. 33 (2), pp. 1022-1030. Date of Electronic Publication: 2022 Sep 06.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Carcinoma, Hepatocellular*/pathology
Chemoembolization, Therapeutic*
Humans ; Hepatectomy ; Treatment Outcome ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Radiologic-pathologic correlation of lesions in resected liver specimens with an ex vivo MRI-compatible localization device.
Autorzy:
Rendell VR; Department of Surgery, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA.
Winslow ER; Department of Surgery, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA.; MedStar Georgetown Transplant Institute, 3800 Reservoir Road Northwest, Pasquerilla Healthcare Center 2nd Fl, Washington, DC, 20007, USA.
Colgan TJ; Department of Radiology, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA.
Kovacs SK; Department of Pathology, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA.
Mühler MR; Department of Radiology, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA.
Knobloch G; Department of Radiology, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA.
Loeffler AG; Department of Pathology, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA.; MetroHealth Medical Center, 2500 Metrohealth Dr, Cleveland, OH, 44109, USA.
Agni RM; Department of Pathology, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA.
Reeder SB; Department of Radiology, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA. .; Department of Medical Physics, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA. .; Department of Biomedical Engineering, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA. .; Department of Medicine, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA. .; Department of Emergency Medicine, University of Wisconsin-Madison, 600 Highland Ave, Madison, WI, 53792, USA. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Jan; Vol. 33 (1), pp. 535-544. Date of Electronic Publication: 2022 Jul 21.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Cysts*/pathology
Adult ; Humans ; Contrast Media/pharmacology ; Prospective Studies ; Gadolinium DTPA ; Liver/diagnostic imaging ; Liver/surgery ; Liver/pathology ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Szczegóły
Tytuł:
The prognostic role of the AST/ALT ratio in hepatocellular carcinoma patients receiving thermal ablation combined with simultaneous TACE.
Autorzy:
Wang F; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Gao S; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Wu M; Department of CT&MRI, Third Hospital of Hebei Medical University, , Shijiazhuang, 050051, Hebei Province, China.
Zhao D; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Sun H; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yav S; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Chen Y; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang Z; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yang M; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Dong Y; Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China.
Wang J; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Wang X; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yan Z; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China. .; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. .
Liu L; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, No.180 Fenglin Road, Xuhui District, Shanghai, 200032, China. .; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Mar 21; Vol. 23 (1), pp. 80. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Chemoembolization, Therapeutic*
Humans ; Prognosis ; Alanine Transaminase ; Retrospective Studies ; Aspartate Aminotransferases ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Integrative epigenetic analysis reveals AP-1 promotes activation of tumor-infiltrating regulatory T cells in HCC.
Autorzy:
Zhuo B; Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, Guangdong, China.; Medical Research Institute, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, 518102, Guangdong, China.
Zhang Q; Department of General Surgery, Division of Hepatobiliopancreatic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Xie T; Medical Research Institute, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, 518102, Guangdong, China.
Wang Y; Department of Laboratory Medicine, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, 518102, Guangdong, China.
Chen Z; Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, Guangdong, China. .
Zuo D; Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, Guangdong, China. .
Guo B; Medical Research Institute, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, 518102, Guangdong, China. .
Pokaż więcej
Źródło:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2023 Mar 20; Vol. 80 (4), pp. 103. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/genetics
Liver Neoplasms*/metabolism
Humans ; T-Lymphocytes, Regulatory ; Transcription Factor AP-1/genetics ; Transcription Factor AP-1/metabolism ; Enhancer Elements, Genetic/genetics ; Epigenesis, Genetic
Czasopismo naukowe
Szczegóły
Tytuł:
ALYREF mediates RNA m C modification to promote hepatocellular carcinoma progression.
Autorzy:
Xue C; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Gu X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zheng Q; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Shi Q; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yuan X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Su Y; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jia J; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jiang J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Lu J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. .
Li L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. .
Pokaż więcej
Źródło:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Mar 18; Vol. 8 (1), pp. 130. Date of Electronic Publication: 2023 Mar 18.
Typ publikacji:
Letter
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Humans ; RNA ; Transcription Factors/genetics ; Nuclear Proteins/genetics ; RNA-Binding Proteins/genetics
Opinia redakcyjna
Szczegóły
Tytuł:
Pre-diagnostic anti-EBV antibodies and primary liver cancer risk: a population-based nested case-control study in southern China.
Autorzy:
Du Y; Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, 528400, People's Republic of China.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 17177, Sweden.
Yu X; Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, 528400, People's Republic of China.
Chang ET; Department of Epidemiology and Biostatistics, University of California, California, USA.
Lian S; Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 17177, Sweden.
Wu B; Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, 528400, People's Republic of China.
Li F; Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, 528400, People's Republic of China.
Chu B; Department of Pathology, Zhongshan City People's Hospital, Zhongshan, 528400, People's Republic of China.
Wei K; Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, 528400, People's Republic of China.
Zhan J; Xiaolan Public Health Service Center, Zhongshan, 528400, People's Republic of China.
Liang X; Xiaolan Public Health Service Center, Zhongshan, 528400, People's Republic of China.
Ye W; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 17177, Sweden. .
Ji M; Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, 528400, People's Republic of China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Mar 15; Vol. 23 (1), pp. 250. Date of Electronic Publication: 2023 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Epstein-Barr Virus Infections*
Liver Neoplasms*/diagnosis
Liver Neoplasms*/epidemiology
Liver Neoplasms*/complications
Nasopharyngeal Neoplasms*/diagnosis
Humans ; Herpesvirus 4, Human ; Case-Control Studies ; Hepatitis B Surface Antigens ; Antigens, Viral ; Capsid Proteins ; China/epidemiology ; Antibodies, Viral ; Immunoglobulin A
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CircFOXK2 promotes hepatocellular carcinoma progression and leads to a poor clinical prognosis via regulating the Warburg effect.
Autorzy:
Zheng J; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Yan X; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Lu T; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Song W; Department of Anesthesiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, 510120, China.
Li Y; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Liang J; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Zhang J; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Cai J; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Sui X; Surgical ICU of the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Xiao J; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Chen H; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Chen G; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Zhang Q; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China. kee_.; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China. kee_.
Liu Y; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .
Yang Y; Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou, 510630, China. .; Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China. .
Zheng K; Department of General Surgery of Guangdong Tongjiang Hospital, Foshan, 528300, China. .
Pan Z; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Mar 15; Vol. 42 (1), pp. 63. Date of Electronic Publication: 2023 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
RNA, Circular*/genetics
Animals ; Humans ; Cell Line, Tumor ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nanosecond pulsed electric field ablates rabbit VX2 liver tumors in a non-thermal manner.
Autorzy:
Li QG; Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Liu ZG; Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Key Laboratory of Pulsed Power Translational Medicine of Zhejiang Province, Hangzhou, China.
Dong G; Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Sun Y; Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zou YW; Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chen XL; Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wu B; Key Laboratory of Pulsed Power Translational Medicine of Zhejiang Province, Hangzhou, China.
Chen XH; Key Laboratory of Pulsed Power Translational Medicine of Zhejiang Province, Hangzhou, China.; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ren ZG; Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Key Laboratory of Pulsed Power Translational Medicine of Zhejiang Province, Hangzhou, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Mar 15; Vol. 18 (3), pp. e0273754. Date of Electronic Publication: 2023 Mar 15 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Actins*
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/therapy
Liver Neoplasms*/metabolism
Animals ; Rabbits ; Proliferating Cell Nuclear Antigen ; Ki-67 Antigen ; Apoptosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma.
Autorzy:
Yao N; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China.
Jiang W; Department of Neurology, Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, People's Republic of China.
Wang Y; Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong, People's Republic of China.
Song Q; Department of Radiology, Wake Forest School of Medicine, Winston-Salem, USA.
Cao X; School of Medicine, Nantong University, Nantong, 226001, Jiangsu, China. .
Zheng W; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China. .
Zhang J; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China. zjane_.
Pokaż więcej
Źródło:
European journal of medical research [Eur J Med Res] 2023 Mar 15; Vol. 28 (1), pp. 123. Date of Electronic Publication: 2023 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Humans ; Immunotherapy ; Interferon-gamma ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Polydopamine-Coated Radiolabeled Microspheres for Combinatorial Radioembolization and Photothermal Cancer Therapy.
Autorzy:
Wu M; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.
Zhang L; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Shi K; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.
Zhao D; Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Yong W; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.
Yin L; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.
Huang R; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.
Wang G; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.
Huang G; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.
Gao M; State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.
Pokaż więcej
Źródło:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2023 Mar 15; Vol. 15 (10), pp. 12669-12677. Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/therapy
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/therapy
Liver Neoplasms*/pathology
Humans ; Microspheres ; Photothermal Therapy
Czasopismo naukowe
Szczegóły
Tytuł:
Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply.
Autorzy:
Yim HJ; Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
Ahn YE; Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
Kim TH; Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
Jung YK; Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2023 Mar 15; Vol. 17 (2), pp. 341-342. Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:
Letter
MeSH Terms:
Carcinoma, Hepatocellular*/complications
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/complications
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Venous Thrombosis*/complications
Venous Thrombosis*/drug therapy
Antineoplastic Agents*/therapeutic use
Humans ; Sorafenib/therapeutic use ; Portal Vein/pathology ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols ; Phenylurea Compounds/therapeutic use
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
Autorzy:
Deng M; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Li S; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Wei W; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Guo R; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2023 Mar 15; Vol. 17 (2), pp. 339-340. Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:
Letter
MeSH Terms:
Carcinoma, Hepatocellular*/complications
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/complications
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Venous Thrombosis*/complications
Venous Thrombosis*/drug therapy
Antineoplastic Agents*/therapeutic use
Humans ; Sorafenib/therapeutic use ; Portal Vein/pathology ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cumulative consumption of tea is associated with lower risk of liver cancer: Updated results from the Shanghai Women's Health Study.
Autorzy:
Li ZY; School of Public Health, Fudan University, Shanghai, China.; State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tan YT; State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liu DK; State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gao LF; State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li HL; State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xiang YB; School of Public Health, Fudan University, Shanghai, China.; State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2023 Mar 15; Vol. 152 (6), pp. 1115-1123. Date of Electronic Publication: 2022 Oct 14.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Middle Aged ; Humans ; Female ; Prospective Studies ; Risk Factors ; China/epidemiology ; Tea ; Women's Health
Czasopismo naukowe
Szczegóły
Tytuł:
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers.
Autorzy:
Hemminki K; Faculty of Medicine and Biomedical Center in Pilsen, Biomedical Center, Charles University in Prague, Pilsen.; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Primary Health Care Research, Lund University, Malmö.
Sundquist K; Center for Primary Health Care Research, Lund University, Malmö.; Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai, Mount Sinai, New York, USA.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Mount Sinai, New York, USA.; Department of Functional Pathology, Center for Community-Based Healthcare Research and Education (CoHRE), School of Medicine, Shimane University, Shimane, Japan.
Sundquist J; Center for Primary Health Care Research, Lund University, Malmö.; Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai, Mount Sinai, New York, USA.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Mount Sinai, New York, USA.; Department of Functional Pathology, Center for Community-Based Healthcare Research and Education (CoHRE), School of Medicine, Shimane University, Shimane, Japan.
Försti A; Center for Primary Health Care Research, Lund University, Malmö.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Liska V; Faculty of Medicine and Biomedical Center in Pilsen, Biomedical Center, Charles University in Prague, Pilsen.; Department of Surgery, University Hospital, School of Medicine in Pilsen, Pilsen, Czech Republic.
Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
Li X; Center for Primary Health Care Research, Lund University, Malmö.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2023 Mar 15; Vol. 152 (6), pp. 1107-1114. Date of Electronic Publication: 2022 Oct 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Liver Neoplasms*/pathology
Ampulla of Vater*/pathology
Common Bile Duct Neoplasms*/complications
Common Bile Duct Neoplasms*/pathology
Cholangiocarcinoma*/epidemiology
Cholangiocarcinoma*/etiology
Cholangiocarcinoma*/diagnosis
Bile Duct Neoplasms*/epidemiology
Bile Duct Neoplasms*/etiology
Bile Duct Neoplasms*/pathology
Gallbladder Neoplasms*/etiology
Gallbladder Neoplasms*/complications
Cholelithiasis*/complications
Cholelithiasis*/pathology
Autoimmune Diseases*
Male ; Humans ; Female ; Bile Ducts, Intrahepatic/pathology ; Inflammation/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
An ER-Horse Detonating Stress Cascade for Hepatocellular Carcinoma Nanotherapy.
Autorzy:
Bian X; The Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.; Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.; Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
Fan N; Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
Li M; The Second Affliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Han D; Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
Li J; Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
Fan L; Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
Li X; Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
Kong L; Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
Tang H; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Ding S; Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
Song F; Molecular Medicine and Cancer Research Center, Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
Li S; Department of Forensic Medicine, Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
Cheng W; The Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
Pokaż więcej
Źródło:
ACS nano [ACS Nano] 2023 Mar 14; Vol. 17 (5), pp. 4896-4912. Date of Electronic Publication: 2023 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/drug therapy
Liver Neoplasms*/metabolism
Humans ; Endoplasmic Reticulum Stress ; Unfolded Protein Response ; Signal Transduction ; Apoptosis
Czasopismo naukowe
Szczegóły
Tytuł:
Engineering orthotopic tumor spheroids with organ-specific vasculatures for local chemoembolization evaluation.
Autorzy:
Gao Y; Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. .
Xiao J; Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. .
Chen Z; Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. .; Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore.
Ma Y; Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. .
Liu X; Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. .
Yang D; Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. .
Leo HL; Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore.
Yu H; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.; Mechanobiology Institute, National University of Singapore, Singapore 117411, Singapore.; Institute of Bioengineering and Nanotechnology, Agency for Science, Technology and Research, Singapore 138669, Singapore.; Singapore-MIT Alliance for Research and Technology, Singapore 138602, Singapore.
Kong J; Department of Interventional Radiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, 518020, China. .
Guo Q; Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. .
Pokaż więcej
Źródło:
Biomaterials science [Biomater Sci] 2023 Mar 14; Vol. 11 (6), pp. 2115-2128. Date of Electronic Publication: 2023 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/therapy
Liver Neoplasms*/pathology
Carcinoma, Hepatocellular*/pathology
Chemoembolization, Therapeutic*/methods
Animals ; Rats ; Portal Vein/pathology ; Spheroids, Cellular/pathology ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma.
Autorzy:
Nguyen VC; National Cancer Hospital, Hanoi, Vietnam.; Hanoi Medical University, Hanoi, Vietnam.
Nguyen TH; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.; Gene Solutions, Ho Chi Minh City, Vietnam.
Phan TH; MEDIC Medical Center, Ho Chi Minh City, Vietnam.
Tran TT; National Cancer Hospital, Hanoi, Vietnam.; Hanoi Medical University, Hanoi, Vietnam.
Pham TTT; MEDIC Medical Center, Ho Chi Minh City, Vietnam.
Ho TD; MEDIC Medical Center, Ho Chi Minh City, Vietnam.
Nguyen HHT; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.; Gene Solutions, Ho Chi Minh City, Vietnam.
Duong ML; National Cancer Hospital, Hanoi, Vietnam.
Nguyen CM; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.; Gene Solutions, Ho Chi Minh City, Vietnam.
Nguyen QB; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.; Gene Solutions, Ho Chi Minh City, Vietnam.
Bach HT; National Cancer Hospital, Hanoi, Vietnam.
Kim VV; National Cancer Hospital, Hanoi, Vietnam.; Hanoi Medical University, Hanoi, Vietnam.
Pham TA; National Cancer Hospital, Hanoi, Vietnam.
Nguyen BT; MEDIC Medical Center, Ho Chi Minh City, Vietnam.
Nguyen TNV; MEDIC Medical Center, Ho Chi Minh City, Vietnam.
Huynh LAK; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.; Virginia Commonwealth University, Richmond, USA.
Tran VU; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.; Gene Solutions, Ho Chi Minh City, Vietnam.
Tran TTT; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.; Gene Solutions, Ho Chi Minh City, Vietnam.
Nguyen TD; MEDIC Medical Center, Ho Chi Minh City, Vietnam.
Phu DTB; MEDIC Medical Center, Ho Chi Minh City, Vietnam.
Phan BHH; MEDIC Medical Center, Ho Chi Minh City, Vietnam.
Nguyen QT; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.
Truong DK; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.
Do TT; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.
Nguyen HN; University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Phan MD; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam.; Gene Solutions, Ho Chi Minh City, Vietnam.
Giang H; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam. .; Gene Solutions, Ho Chi Minh City, Vietnam. .
Tran LS; Medical Genetics Institute, 186 Nguyen Duy Duong, Ward 3, District 10, Ho Chi Minh City, Vietnam. .; Gene Solutions, Ho Chi Minh City, Vietnam. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Mar 13; Vol. 23 (1), pp. 233. Date of Electronic Publication: 2023 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/genetics
Circulating Tumor DNA*
Liver Neoplasms*/diagnosis
Liver Neoplasms*/genetics
Humans ; Prospective Studies ; Biomarkers, Tumor/genetics ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 77224

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz